The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(1-(4-Chlorobenzyl)-1H-indole-2-carbonyl)-N-(2-(pyridin-4-yl)-ethyl)piperidine-4-carboxamide ID: ALA3085944
PubChem CID: 66571217
Max Phase: Preclinical
Molecular Formula: C29H29ClN4O2
Molecular Weight: 501.03
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCCc1ccncc1)C1CCN(C(=O)c2cc3ccccc3n2Cc2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C29H29ClN4O2/c30-25-7-5-22(6-8-25)20-34-26-4-2-1-3-24(26)19-27(34)29(36)33-17-12-23(13-18-33)28(35)32-16-11-21-9-14-31-15-10-21/h1-10,14-15,19,23H,11-13,16-18,20H2,(H,32,35)
Standard InChI Key: ZCSWCGKOEUTHLD-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
30.1855 -26.2970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6799 -25.6428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2106 -24.9706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5351 -24.2120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1236 -23.4961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5055 -25.6583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9048 -26.3810 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9317 -24.9511 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4740 -27.0861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8699 -27.8066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6957 -27.8263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1241 -27.1193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7266 -26.3925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5436 -22.7795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1355 -22.0658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3095 -22.0600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8932 -22.7742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3028 -23.4942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0923 -28.5506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6634 -29.2561 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.9178 -28.5692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.4107 -26.0289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4299 -25.2114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7326 -24.7878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0156 -25.1807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0003 -26.0013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6983 -26.4212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9007 -21.3427 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
34.3144 -29.2934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1399 -29.3120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5365 -30.0363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1040 -30.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5000 -31.4618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3263 -31.4809 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7552 -30.7702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3568 -30.0494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22 1 1 0
1 2 2 0
2 3 1 0
3 23 1 0
3 4 1 0
4 5 1 0
2 6 1 0
6 7 1 0
6 8 2 0
7 9 1 0
7 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
5 14 2 0
5 18 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
11 19 1 0
19 20 2 0
19 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
16 28 1 0
21 29 1 0
29 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 501.03Molecular Weight (Monoisotopic): 500.1979AlogP: 4.95#Rotatable Bonds: 7Polar Surface Area: 67.23Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 5.05CX LogP: 4.13CX LogD: 4.13Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.39Np Likeness Score: -1.57
References 1. Sindac JA, Barraza SJ, Dobry CJ, Xiang J, Blakely PK, Irani DN, Keep RF, Miller DJ, Larsen SD.. (2013) Optimization of novel indole-2-carboxamide inhibitors of neurotropic alphavirus replication., 56 (22): [PMID:24151954 ] [10.1021/jm401330r ] 2. Barraza SJ, Delekta PC, Sindac JA, Dobry CJ, Xiang J, Keep RF, Miller DJ, Larsen SD.. (2015) Discovery of anthranilamides as a novel class of inhibitors of neurotropic alphavirus replication., 23 (7): [PMID:25740634 ] [10.1016/j.bmc.2015.01.054 ] 3. Barraza SJ, Sindac JA, Dobry CJ, Delekta PC, Lee PH, Miller DJ, Larsen SD.. (2021) Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore., 46 [PMID:34098081 ] [10.1016/j.bmcl.2021.128171 ]